DRKS00026025Recruiting未知
Follow-up study to evaluate the role of circulating cell-derived extracellular vesicles (EVs) in polytrauma
Bundeswehrzentralkrankenhaus Koblenz0 sites80 target enrollmentStarted: August 11, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Trauma patient with ISS >9
Exclusion Criteria
- •No declaration of consent, pregnancy, participants unter 18 years old, doubts about the patient's ability to consent or signs of dementia, as well as incomplete blood collection series. In addition, patients with acute or chronic inflammation, e.g., autoimmune hepatitis, but also genetic diseases, cholestatic diseases, and patients with co-infection, such as HCV and HBV or HCV and HIV, are excluded, as these have been shown to alter the fibrolytic EV profile.
Investigators
Similar Trials
Completed
Not Applicable
Clinical evaluation for the response of circulating endothelial progenitor cells and lung injury severity after surgerycases of general anesthesiaJPRN-UMIN000017392department of anesthesiology and perioperative medicine20
Completed
Not Applicable
Central Australia Swab Study: an assessment of circulating respiratory pathogens in a remote Indigenous communityACTRN12609001006235Menzies School of Health Research140
Completed
Not Applicable
ANGIO-EX study: to determine whether the blood circulating protein angiopoietin like-2 (angptl2) is associated with a poor vessel health in young and old healthy volunteers, patients with a coronary artery heart disease and in obese subjectsISRCTN46169845Montreal Heart Institute (Canada)80
Not yet recruiting
Not Applicable
Prospective characterisation of a novel circulating tumour-derived DNA methylation assay to monitor tumour burden and response to therapy in metastatic colorectal cancer (CATCHER-1)metastatic colorectal cancerACTRN12618001116213Monash Health50
Completed
Not Applicable
A study to determine the effect of post-infusion cooling time in the high dose 5-fluorouracil, 4-epidoxorubicin and cyclophosphamide (FEC)-regimeBreast cancer, hair lossCancerISRCTN97879847Medical Centre Alkmaar (Medisch Centrum Alkmaar) (The Netherlands)130